The rise of methicillin-resistant Staphylococcus aureus (MRSA) and other resistant organisms is a serious concern for all physicians who deal with infection. Bacteria would not have survived for billions of years were they not brilliantly able to adapt to changed environments. As bacteria develop resistance to the drugs we use to treat infection, we need increasingly potent antibiotics to help keep them in check.
Now that more physicians and patients have access to SLT, it is important to understand how this modality best fits into the management of patients with glaucoma. Since not all patients respond equally to SLT, isolating the factors that can help to determine the likelihood that a patient will respond successfully to treatment with SLT is an important step in glaucoma management. Watch the video interview with Dr. Hutnik to learn more.
The Academy is thrilled to return to The Big Easy for the 2013 Annual Meeting! Join us at the Ernest N. Morial Convention Center in New Orleans for our 117th Annual Meeting.
